Alt COVID-19 Therapy


Singapore, Singapore

Short Summary

Opportunity to pivot the scourge of COVID-19 through CoviTone, an efficacious, cost-effective, alternative treatment solution against different forms of coronaviruses such as SARS-CoV-1, SARS-CoV-2, MERS-CoV), by disrupting the virus’s replication.


Investment Raised
Previous Rounds N/A
Stage Pre-Startup/R&D
Investor Role


  • Cost-Effective, efficacious alternative therapy for COVID-19
  • Taken via oral ingestion avoiding injections
  • Successfully completed safety trials
  • Strong suite of proprietary trade secret and patent
  • Solution against different forms of coronaviruses
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Global Pro
0% raised

SurgeryVision by ADESANTE

location_on Finland

Are you willing to get temporary or permanently injured or even facing a wrongful death due to surgical failures if you need a surgery? Me neither, but those events happens and that`s why the SurgeryVision is needed.

S$ 5,000,000


S$ 250,000

Min per Investor

0% raised

Ferne Health At-home Test

location_on Singapore, Singapore

Ferne Health is aiming to build the first one-stop sexual health platform for women in Asia to learn, consult, test, and treat themselves in the privacy and convenience of their own home.

S$ 150,000


S$ 50,000

Min per Investor

Global Pro
0% raised

Big Consumer Market

location_on Antwerp, Belgium

Overview and Background CannIBite (the “Company”) is a US & European based private company developing effective & innovative oral health care solutions for high unmet oral care treatment needs.

S$ 3,100,000


S$ 79,000

Min per Investor

load one similar proposal